Month December 2024

Q32 Bio advances bempikibart for alopecia remedy

WALTHAM, Mass. – Q32 Bio Inc. (NASDAQ: QTTB), a biotechnology agency specializing in immune system therapeutics, has introduced plans to progress its drug candidate bempikibart after observing promising ends in a medical trial for alopecia areata (AA). The corporate, presently…